Table I.
Effect of DADS and Src inhibitor treatments on the migration ability of HHDN cells.
| Group | No treatment group | DADS-treated group | Src inhibitor-treated group | Combined treatment group |
|---|---|---|---|---|
| HHDN | 1.514±0.04a | 1.117±0.03b,a | 1.163±0.02b,a | 0.929±0.04c,a |
| HL-60 | 1.136±0.05 | 0.739±0.04b | 0.775±0.02b | 0.516±0.03c |
a
P<0.05 vs. the control group
b
P<0.05 vs. the untreated group
c
P<0.05 vs. the DADS group and Src inhibitor group. DADS, diallyl disulfide; HHND, HL-60 cells with a high expression of DJ-1 in the nucleus; DJ-1, parkinsonism associated deglycase.